....the cost of a drug needed to combat toxoplasmosis and other
infections from $13.50 to $750?

Well, he just got it up the ass...





Imprimis forms Imprimis Cares to help combat the high prices of sole
source legacy generic drugs

Oct 22, 2015

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.
(NASDAQ: IMMY), a specialty pharmaceutical company focused on the
development and commercialization of proprietary compounded drug
therapies, today announced it has made available a customizable
compounded formulation of pyrimethamine and leucovorin available for
physicians to consider prescribing for their patients as a low cost
alternative to Daraprim®.

Last month, Turing Pharmaceuticals LLC, the sole supplier of Daraprim,
increased the price of this prescription drug from $13.50 per tablet to
a reported $750.00 per tablet. The FDA-approved label for Daraprim
indicates that it is prescribed for toxoplasmosis and other types of
infections. Toxoplasmosis can be of major concern for patients with
weakened immune systems such as patients with HIV/AIDS, pregnant women
and children. According to the Centers for Disease Control and
Prevention, pyrimethamine works to block folic acid synthesis in the
parasite T. gondii, the cause of toxoplasmosis, and leucovorin helps to
reverse the negative effects on bone marrow caused by this mechanism of
action.

Imprimis is now offering customizable compounded formulations of
pyrimethamine and leucovorin in oral capsules starting as low as $99.00
for a 100 count bottle, or at a cost of under a dollar per capsule.
Compounded medications may be appropriate for prescription when a
commercially-available medicine does not meet the specific needs of a
patient. For ordering information, please visit www.imprimiscares.com.

On 10/23/2015 9:21 AM, Keyser Söze wrote:
...the cost of a drug needed to combat toxoplasmosis and other
infections from $13.50 to $750?

Well, he just got it up the ass...





Imprimis forms Imprimis Cares to help combat the high prices of sole
source legacy generic drugs

Oct 22, 2015

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.
(NASDAQ: IMMY), a specialty pharmaceutical company focused on the
development and commercialization of proprietary compounded drug
therapies, today announced it has made available a customizable
compounded formulation of pyrimethamine and leucovorin available for
physicians to consider prescribing for their patients as a low cost
alternative to Daraprim®.

Last month, Turing Pharmaceuticals LLC, the sole supplier of Daraprim,
increased the price of this prescription drug from $13.50 per tablet to
a reported $750.00 per tablet. The FDA-approved label for Daraprim
indicates that it is prescribed for toxoplasmosis and other types of
infections. Toxoplasmosis can be of major concern for patients with
weakened immune systems such as patients with HIV/AIDS, pregnant women
and children. According to the Centers for Disease Control and
Prevention, pyrimethamine works to block folic acid synthesis in the
parasite T. gondii, the cause of toxoplasmosis, and leucovorin helps to
reverse the negative effects on bone marrow caused by this mechanism of
action.

Imprimis is now offering customizable compounded formulations of
pyrimethamine and leucovorin in oral capsules starting as low as $99.00
for a 100 count bottle, or at a cost of under a dollar per capsule.
Compounded medications may be appropriate for prescription when a
commercially-available medicine does not meet the specific needs of a
patient. For ordering information, please visit www.imprimiscares.com.


Love it. Free market competition at work.

On 10/23/2015 8:49 AM, Mr. Luddite wrote:
On 10/23/2015 9:21 AM, Keyser Söze wrote:
...the cost of a drug needed to combat toxoplasmosis and other
infections from $13.50 to $750?

Well, he just got it up the ass...





Imprimis forms Imprimis Cares to help combat the high prices of sole
source legacy generic drugs

Oct 22, 2015

SAN DIEGO, Oct. 22, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.
(NASDAQ: IMMY), a specialty pharmaceutical company focused on the
development and commercialization of proprietary compounded drug
therapies, today announced it has made available a customizable
compounded formulation of pyrimethamine and leucovorin available for
physicians to consider prescribing for their patients as a low cost
alternative to Daraprim®.

Last month, Turing Pharmaceuticals LLC, the sole supplier of Daraprim,
increased the price of this prescription drug from $13.50 per tablet to
a reported $750.00 per tablet. The FDA-approved label for Daraprim
indicates that it is prescribed for toxoplasmosis and other types of
infections. Toxoplasmosis can be of major concern for patients with
weakened immune systems such as patients with HIV/AIDS, pregnant women
and children. According to the Centers for Disease Control and
Prevention, pyrimethamine works to block folic acid synthesis in the
parasite T. gondii, the cause of toxoplasmosis, and leucovorin helps to
reverse the negative effects on bone marrow caused by this mechanism of
action.

Imprimis is now offering customizable compounded formulations of
pyrimethamine and leucovorin in oral capsules starting as low as $99.00
for a 100 count bottle, or at a cost of under a dollar per capsule.
Compounded medications may be appropriate for prescription when a
commercially-available medicine does not meet the specific needs of a
patient. For ordering information, please visit www.imprimiscares.com.


Love it. Free market competition at work.

You beat me to it! It gives you a warm cushy feel, eh?
Mikek